Document is current
Any future updates will be listed below
-
Authors
Miller, David M.
- License Information
-
More Information
Article History
Received: 9 December 2024
Revised: 24 January 2025
Accepted: 27 January 2025
First Online: 26 February 2025
Declarations
:
: I have received honoraria for participation on advisory boards for Merck, EMD Serono, Regeneron, Sanofi Genzyme, Pfizer, Castle Biosciences, Checkpoint Therapeutics, Incyte, Bristol-Myers Squib, Amirall. I have stock options from Checkpoint Therapeutics and Avstera Therapeutics. I have received research funding from Regeneron, Kartos Therapeutics, Xilio Therapeutics, NeoImmune Tech, Inc, Project Data Sphere, ECOG-ACRIN and the American Skin Association.
